Drug-Price Transparency Won’t End the Patent Games

Bookmark
(Bloomberg Opinion) -- Late last week, Sandoz Inc., the generics division of Novartis AG, settled a patent lawsuit with AbbVie Inc. over Humira, a so-called biologic drug that treats rheumatoid art...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.